Heartmate ii left ventricular assist device extensive driveline fracture: hanging on by a thread

Migration of a HeartMate II left ventricular assist device.

Surgical technique influences HeartMate II left ventricular assist device thrombosis.

BACKGROUND Thrombosis of the HeartMate II (HM2 [Thoratec Corporation, Pleasanton, CA]) is a potentially devastating complication. While attention has been focused on anticoagulation strategies to prevent this complication, the impact of surgical technique has not been assessed. METHODS Patients undergoing HM2 implantation at two institutions were reviewed. Pump thrombosis (PT) was defined as ...

HeartMate II left ventricular assist device; early European experience.

OBJECTIVE The novel axial flow left ventricular assist device HeartMate II was introduced into clinical practice in Europe as part of the pilot study and after CE approval in November 2005. In order to get an overview of the use and performance of the device in Europe a group of investigators was founded to compare the initial results. METHODS In a retrospective analysis of the first 101 cons...

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation

BACKGROUND HeartMate II (HM II) and HeartWare (HW) Left Ventricular Assist Devices have been successfully used in end-stage heart failure patients as a bridge to transplantation, recovery, or decision. We set out to compare their effect in off-loading the left ventricle and its geometry. METHODS The left ventricular end diastolic (LVEDD) and end systolic (LVESD) diameters were compared betwee...

Evaluation of bend relief disconnection in patients supported by a HeartMate II left ventricular assist device.

L eft ventricular assist devices (LVADs) are an established treatment for patients with end-stage heart failure as either a bridge to cardiac transplantation 1 or as lifelong support, also known as destination therapy.) is a continuous flow device that was approved by the US Food and Drug Administration in 2008, after a pivotal trial in 133 patients awaiting transplantation. 3 More patients hav...